ClinicalTrials.Veeva

Menu

Prospective Quality of Life Study in Pituitary Surgery

University of Virginia logo

University of Virginia

Status

Unknown

Conditions

Endoscopic Skull Base Surgery
Postoperative Period
Post Operative Care

Treatments

Other: Follow-up schedule

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Post-operative assessment and debridement are key components in patient care for surgery patients. However, a standardized protocol for management after endoscopic skull base surgery is unavailable. In this study, investigators will observe the effect of various follow-up schedules on the patient's quality of life after surgery. Patients who received surgery for pituitary adenoma will be placed randomly in 1 of 3 groups (short-term = follow-up in 2 weeks and 8 weeks after surgery; intermediate = 4 weeks and 8 weeks; long-term = 8 weeks). At each visit, patients will be asked to complete a packet of surveys and questionnaires that provide metrics on their quality of life in addition to receiving standard patient care (post-operative assessment and nasal debridement). Researchers hope to find that a follow-up schedule that has patients visiting the clinic closer to their surgery date will increase the patient's quality of life after surgery.

Enrollment

165 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has surgery for pituitary adenoma at UVA after May 1st, 2018
  • Has sellar and parasellar pathology
  • ≥ 18 years old
  • Can complete all parts of study in English

Exclusion criteria

  • Extended approaches
  • Use of naso-septal flap during the current surgical procedure
  • Septoplasty
  • Prior history of Chronic Rhinosinusitis (CRS)
  • Prior history of sphenoidotomy
  • < 18 years old
  • Prisoner

Trial design

165 participants in 3 patient groups

Short-term
Description:
Patients will be scheduled for PO follow-up visits 2 weeks, and 8 weeks after surgery.
Treatment:
Other: Follow-up schedule
Intermediate
Description:
Patients will be scheduled for PO follow-up visits 4 weeks, and 8 weeks after surgery.
Treatment:
Other: Follow-up schedule
Long-term
Description:
Patients will be scheduled for PO follow-up visits 8 weeks after surgery.
Treatment:
Other: Follow-up schedule

Trial contacts and locations

0

Loading...

Central trial contact

Karis Ra, BA; Jose Mattos, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems